CCL21 and neoplasm: Our results shed light on the function of host-derived CCL21 in tumor growth in vivo. We have demonstrated for the first time that B16–F10, a poorly immunogenic cell line widely used in the studies of tumor-induced T cell anergy [24], efficiently elicited immune response in the absence of host-derived CCL21-Ser.